Researchers collected magnetic resonance imaging that showed that patients with schizo-obsessive comorbidity had extensive cortico-subcortical and perceptual processing-related white matter changes compared with patients have either schizophrenia or obsessive compulsive disorder.
A recent meta-analysis showed that approximately 1 in 5 women met diagnostic criteria for at least one anxiety disorder during pregnancy or postpartum.
Based on improved symptoms measured by the 6-item Hamilton Depression Rating Scale, SSRIs appear to be as effective in patients with nonsevere depression as in patients with severe depression.
The US Preventive Services Task Force recommends screening for illicit drug use in adults; the draft is available for public comment through Sept. 9, 2019.
Depression in adolescence, a rising concern, might be influenced by television and social media exposure.
Misuse of prescription drugs is common among high school students, and those misusing prescription drugs frequently obtain them from multiple sources.
After electroconvulsive therapy for patients with depression, researchers suggest that an increase in the thickness of the right lateral orbitofrontal cortex was linked to a significantly greater antidepressant effect.
The compensatory strategies employed by individuals with autism spectrum disorder might be a barrier to an official, timely diagnosis of autism, and might have negative consequences on individual’s mental health and well-being.
Cariprazine significantly reduced mixed features in patients with bipolar I disorder.
The Food and Drug Administration (FDA) approved Wakix (pitolisant; Harmony Biosciences) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.
Please login or register first to view this content.
